Search research articles
Contact Us
Filters
Showing results (11-20 of 50) with videos related to
Page
of 5
Sort By:
Clinical and Translational Science
|
February 22, 2025
Integrating early response biomarkers in pharmacokinetic models: A novel method to individualize the initial infliximab dose in patients with Crohn's disease
Abigail Samuels, Kei Irie, Tomoyuki Mizuno, et al.
Inflammatory Bowel Diseases
|
December 23, 2017
Validation of Neutrophil CD64 Blood Biomarkers to Detect Mucosal Inflammation in Pediatric Crohn's Disease
Phillip Minar, Kimberly Jackson, Yi-Ting Tsai, et al.
Journal of Pediatrics, Perinatology and Child Health
|
April 25, 2024
De Novo Crohn's Disease Diagnosed in the Setting of Acute SARS-Cov-2 Infection Requiring Escalation of Infliximab Therapy Guided by Personalized Pharmacokinetics
Martin Varea Romo, Kishor Acharya, Nathan R Shelman, et al.
Crohn'S & Colitis 360
|
November 1, 2019
Elevated Pretreatment Plasma Oncostatin M Is Associated With Poor Biochemical Response to Infliximab
Phillip Minar, Christina Lehn, Yi-Ting Tsai, et al.
Inflammatory Bowel Diseases
|
May 20, 2020
Favorable Outcomes and Anti-TNF Durability After Addition of an Immunomodulator for Anti-Drug Antibodies in Pediatric IBD Patients
Ruben J Colman, Andrea Portocarrero-Castillo, Deepika Chona, et al.
Journal of Pediatric Gastroenterology and Nutrition
|
June 25, 2019
Development of Infliximab Target Concentrations During Induction in Pediatric Crohn Disease Patients
Kathryn Clarkston, Yi-Ting Tsai, Kimberly Jackson, et al.
Journal of Pediatric Gastroenterology and Nutrition
|
May 15, 2020
A Micro-longitudinal Approach to Measuring Medication Adherence in Pediatric Inflammatory Bowel Diseases
Jill M Plevinsky, Lee A Denson, Jenny Hellmann, et al.
Therapeutic Drug Monitoring
|
June 3, 2025
Machine Learning Modeling for Predicting Infliximab Pharmacokinetics in Pediatric and Young Adult Patients With Crohn Disease: Leveraging Ensemble Modeling With Synthetic and Real-World Data
Kei Irie, Phillip Minar, Jack Reifenberg, et al.
Biorxiv : the Preprint Server for Biology
|
August 12, 2025
Model-informed Deep Q-Networks to Guide Infliximab Dosing in Pediatric Crohn's Disease
Kei Irie, Phillip Minar, Jack Reifenberg, et al.
Clinical Pharmacokinetics
|
August 30, 2025
Hybrid Population Pharmacokinetic-Machine Learning Modeling to Predict Infliximab Pharmacokinetics in Pediatric and Young Adult Patients with Crohn's Disease
Kei Irie, Phillip Minar, Jack Reifenberg, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 50) with videos related to
Sort By:
Page
of 5
Clinical and Translational Science
|
February 22, 2025
Integrating early response biomarkers in pharmacokinetic models: A novel method to individualize the initial infliximab dose in patients with Crohn's disease
Abigail Samuels, Kei Irie, Tomoyuki Mizuno, et al.
Inflammatory Bowel Diseases
|
December 23, 2017
Validation of Neutrophil CD64 Blood Biomarkers to Detect Mucosal Inflammation in Pediatric Crohn's Disease
Phillip Minar, Kimberly Jackson, Yi-Ting Tsai, et al.
Journal of Pediatrics, Perinatology and Child Health
|
April 25, 2024
De Novo Crohn's Disease Diagnosed in the Setting of Acute SARS-Cov-2 Infection Requiring Escalation of Infliximab Therapy Guided by Personalized Pharmacokinetics
Martin Varea Romo, Kishor Acharya, Nathan R Shelman, et al.
Crohn'S & Colitis 360
|
November 1, 2019
Elevated Pretreatment Plasma Oncostatin M Is Associated With Poor Biochemical Response to Infliximab
Phillip Minar, Christina Lehn, Yi-Ting Tsai, et al.
Inflammatory Bowel Diseases
|
May 20, 2020
Favorable Outcomes and Anti-TNF Durability After Addition of an Immunomodulator for Anti-Drug Antibodies in Pediatric IBD Patients
Ruben J Colman, Andrea Portocarrero-Castillo, Deepika Chona, et al.
Journal of Pediatric Gastroenterology and Nutrition
|
June 25, 2019
Development of Infliximab Target Concentrations During Induction in Pediatric Crohn Disease Patients
Kathryn Clarkston, Yi-Ting Tsai, Kimberly Jackson, et al.
Journal of Pediatric Gastroenterology and Nutrition
|
May 15, 2020
A Micro-longitudinal Approach to Measuring Medication Adherence in Pediatric Inflammatory Bowel Diseases
Jill M Plevinsky, Lee A Denson, Jenny Hellmann, et al.
Therapeutic Drug Monitoring
|
June 3, 2025
Machine Learning Modeling for Predicting Infliximab Pharmacokinetics in Pediatric and Young Adult Patients With Crohn Disease: Leveraging Ensemble Modeling With Synthetic and Real-World Data
Kei Irie, Phillip Minar, Jack Reifenberg, et al.
Biorxiv : the Preprint Server for Biology
|
August 12, 2025
Model-informed Deep Q-Networks to Guide Infliximab Dosing in Pediatric Crohn's Disease
Kei Irie, Phillip Minar, Jack Reifenberg, et al.
Clinical Pharmacokinetics
|
August 30, 2025
Hybrid Population Pharmacokinetic-Machine Learning Modeling to Predict Infliximab Pharmacokinetics in Pediatric and Young Adult Patients with Crohn's Disease
Kei Irie, Phillip Minar, Jack Reifenberg, et al.
Page
of 5